# Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy

> **NCT00383812** · NA · UNKNOWN · sponsor: **Asan Medical Center** · enrollment: 20 (—)

## Conditions studied

- Polypoidal Choroidal Vasculopathy

## Interventions

- **DRUG:** Intravitreal Bevacizumab

## Key facts

- **NCT ID:** NCT00383812
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-05
- **Primary completion:** —
- **Final completion:** 2008-05
- **Target enrollment:** 20 (—)
- **Last updated:** 2006-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00383812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00383812, "Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00383812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*